Results
|
10901.
|
|
|
10902.
|
|
|
10903.
|
|
|
10904.
|
|
|
10905.
|
|
|
10906.
|
|
|
10907.
|
|
|
10908.
|
|
|
10909.
|
|
|
10910.
|
|
|
10911.
|
|
|
10912.
|
|
|
10913.
|
Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study. [electronic resource] by
- Auliac, J B
- Chouaid, C
- Greillier, L
- Greiller, L
- Monnet, I
- Le Caer, H
- Falchero, L
- Corre, R
- Descourt, R
- Bota, S
- Berard, H
- Schott, R
- Bizieux, A
- Fournel, P
- Labrunie, A
- Marin, B
- Vergnenegre, A
Producer: 20150511
In:
Lung cancer (Amsterdam, Netherlands) vol. 85
Availability: No items available.
|
|
10914.
|
|
|
10915.
|
|
|
10916.
|
|
|
10917.
|
|
|
10918.
|
|
|
10919.
|
|
|
10920.
|
|